Filing Flows › Dentsply Sirona (XRAY) › Q2 2026 › vs Q2 2025
Dentsply Sirona (XRAY) Q2 2026 vs Q2 2025 (year over year)
Dentsply Sirona's revenue fell $38.0M (-4%) from $936M in Q2 2025 to $898M in Q2 2026. Gross margin 54.9% against 52.4% (+2.5 pts).
Dentsply Sirona, Q2 2026: revenue $898M (-4% year over year), operating margin 9.1%, net earnings $37.0M, operating cash flow $99.0M. The chart draws each line against Q2 2025, the increases inside each band.
Margins
| Q2 2026 | Q2 2025 | Change | |
|---|---|---|---|
| Gross margin | 54.9% | 52.4% | +2.5 pts |
| Operating margin | 9.1% | -13.7% | +22.8 pts |
| Net margin | 4.1% | -4.8% | +8.9 pts |
| Free cash flow margin | 6.1% | 1.7% | +4.4 pts |
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $898M | $936M | −$38.0M | -4% |
| Gross profit | $493M | $490M | $3.0M | +0.6% |
| Cost of revenue | $405M | $446M | −$41.0M | -9% |
| Operating profit | $82.0M | −$128M | $210M | — |
| Operating expenses | $411M | $618M | −$207M | -33% |
| Pre-tax earnings | $72.0M | −$153M | $225M | — |
| Other expense, net | $10.0M | $25.0M | −$15.0M | -60% |
| Research & development | $45.0M | $37.0M | $8.0M | +22% |
| SG&A | $364M | $342M | $22.0M | +6% |
| Other operating costs | $2.0M | $239M | −$237M | -99% |
| Loss borne by minority interests | $1.0M | −$1.0M | $2.0M | — |
| Net earnings | $37.0M | −$45.0M | $82.0M | — |
| Income tax | $36.0M | −$109M | $145M | — |
| Depreciation & amortization | $85.0M | $88.0M | −$3.0M | -3% |
| Share-based compensation | $9.0M | $9.0M | $0 | 0% |
| Working capital & other | $32.0M | $4.0M | $28.0M | +700% |
| Operating cash flow | $99.0M | $48.0M | $51.0M | +106% |
| Free cash flow (OCF − capex) | $55.0M | $16.0M | $39.0M | +244% |
| Capital expenditures | $44.0M | $32.0M | $12.0M | +38% |
Questions
How much did Dentsply Sirona's revenue grow year over year in Q2 2026?
Dentsply Sirona's revenue fell $38.0M (-4%) from $936M in Q2 2025 to $898M in Q2 2026. Gross margin 54.9% against 52.4% (+2.5 pts).